drugset / Trial / NCT00723606
A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With Agitation
RandomizedParallel-groupOpen-labelTreatment
Summary
This local registration study is to confirm the hypothesis of the efficacy, tolerability and safety of ziprasidone IM (intramuscular) in the Chinese population with agitation in schizophrenia
Timeline
- Start
- 2008-09
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Haloperidol | Other / unclassified | 5 mg | Intramuscular |
| Subject | Ziprasidone | Small molecule | 10 mg | Intramuscular |
| Subject | Ziprasidone | Small molecule | 20 mg | Intramuscular |